Clinical Trials Logo
  1. Home
  2. Seizure Disorder
  3. NCT01978470

External Trigeminal Nerve Stimulation for Drug Resistent Epilepsy — eTNS for DRE  

Seizure Disorder Clinical Trial

Official title:
External Trigeminal Nerve Stimulation for Epilepsy

Clinical Trial Summary

The purpose of this study is to evaluate the tolerability and safety of the NeuroSigma eTNS system.

Clinical Trial Description

This study evaluates the safety and tolerability of the NeuroSigma eTNS system for the treatment of drug resistent partial seizures.

Up to 20 subjects, ages 18 - 75, with partial epilepsy will be enrolled in an acute 4-week tolerability study at Olive View/UCLA Medical Center .......

Enrolled subjects will be asked to maintain an accurate seizure calendar, and will be seen at the initial visit, then at two and four weeks....... ;

Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01978470
Study type Interventional
Source NeuroSigma, Inc.
Contact
Status Active, not recruiting
Phase N/A
Start date June 2012
Completion date August 2016
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT01450423 - Physical Exercise in Subjects With Juvenile Myoclonic Epilepsy Phase 2
Active, not recruiting NCT03441867 - Neuroimaging Biomarker for Seizures N/A
Terminated NCT03790436 - Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet N/A
Recruiting NCT01762215 - Policy on Optimal Epilepsy Management N/A
Completed NCT01941706 - Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT N/A
Completed NCT00179426 - Effect of Antiseizure Medication on Hormone Levels and Sexual Function in Men With Epilepsy N/A
Terminated NCT01545518 - IVIG Treatment for Refractory Immune-Related Adult Epilepsy Phase 2
Completed NCT00433667 - A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. Phase 3
Completed NCT00425282 - A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. Phase 3
Withdrawn NCT04377425 - COVID-19 Prevalence and Cognitive Deficits in Neurological Patients
Completed NCT03480555 - Replacing Protein Via Enteral Nutrition in a Stepwise Approach in Critically Ill Patients N/A
Completed NCT03513757 - Dexmedetomidine and Propofol for Pediatric MRI Sedation Phase 4
Not yet recruiting NCT04291716 - Study to Validate Novel Seizure-Detection Algorithm N/A
Recruiting NCT06265103 - Epilepsy Learning Healthcare System (ELHS)
Recruiting NCT03484039 - Incorporating Multidimensional Psychosocial Interventions Improves the Well-being of Individuals With Epilepsy N/A
Completed NCT00179517 - Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo Phase 2
Active, not recruiting NCT04553757 - Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma
Recruiting NCT03233399 - Modulating Movement Intention Via Cortical Stimulation N/A
Completed NCT04439656 - Detecting Absence Seizures Using Eye Tracking
Withdrawn NCT04102254 - Thalamic Stimulation for Epilepsy Study N/A